Finch Therapeutics Group Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 28 Mar 24 | SellUS$21,246 | Jeffery Smisek | Individual | 8,242 | US$2.61 | |
| 22 Nov 23 | SellUS$5,351 | Jeffery Smisek | Individual | 1,470 | US$3.64 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 1 | 0.0000623% |
| Individual Insiders | 709,740 | 44.2% |
| General Public | 896,022 | 55.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 421,381 | US$5.1m | 0% | no data | |||
| 160,366 | US$1.9m | 0% | no data | |||
| 63,434 | US$770.7k | 0% | no data | |||
| 42,253 | US$513.4k | 549% | no data | |||
| 21,206 | US$257.7k | 0% | no data | |||
| 933 | US$11.3k | 0% | no data | |||
| 167 | US$2.0k | 0% | no data | |||
| 1 | US$11.7 | 0% | no data |